Autonomic Modulation for the Management of Patients with Chronic Heart Failure

Circulation: Heart Failure

Volumn 8, Issue 3, 2015, Pages 619-628

  Schwartz, Peter J ^a   La Rovere, Maria Teresa ^b   De Ferrari, Gaetano M ^c,d   Mann, Douglas L ^e  

^a ISTITUTO AUXOLOGICO ITALIANO   (Italy)

^b IRCCS   (Italy)

^c FONDAZIONE IRCCS POLICLINICO SAN MATTEO   (Italy)

^d UNIVERSITY OF PAVIA   (Italy)

^e WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

autonomic nervous system; baroreceptors; spinal cord stimulation; sympathetic denervation; vagus nerve stimulation

Indexed keywords

ARTICLE; BARORECEPTOR ACTIVATION THERAPY; DENERVATION; HEART FAILURE; HEART LEFT VENTRICLE EJECTION FRACTION; HEART LEFT VENTRICLE ENDSYSTOLIC VOLUME; HOSPITALIZATION; HUMAN; KIDNEY DENERVATION; LEFT CARDIAC SYMPATHETIC DENERVATION; NEUROMODULATION; NEW YORK HEART ASSOCIATION CLASS; PRESSORECEPTOR; PRIORITY JOURNAL; QUALITY OF LIFE; SPINAL CORD STIMULATION; VAGUS NERVE STIMULATION; ANIMAL; AUTONOMIC NERVOUS SYSTEM; CHRONIC DISEASE; CONVALESCENCE; HEART; HEART LEFT VENTRICLE FUNCTION; INNERVATION; KIDNEY; PATHOPHYSIOLOGY; PRESSORECEPTOR REFLEX; PROCEDURES; SYMPATHECTOMY; TREATMENT OUTCOME;

ANIMALS; AUTONOMIC NERVOUS SYSTEM; BAROREFLEX; CHRONIC DISEASE; HEART; HEART FAILURE; HUMANS; KIDNEY; PRESSORECEPTORS; RECOVERY OF FUNCTION; SPINAL CORD STIMULATION; SYMPATHECTOMY; TREATMENT OUTCOME; VAGUS NERVE STIMULATION; VENTRICULAR FUNCTION, LEFT;

EID: 84938527563     PISSN: 19413289     EISSN: 19413297     Source Type: Journal    
DOI: 10.1161/CIRCHEARTFAILURE.114.001964     Document Type: Article

References (64)

1. Mann DL, Bristow MR. Mechanisms and models in heart failure: the biomechanical model and beyond. Circulation. 2005;111:2837-2849. doi: 10.1161/CIRCULATIONAHA.104.500546.
2. Schwartz PJ, De Ferrari GM. Sympathetic-parasympathetic interaction in health and disease: abnormalities and relevance in heart failure. Heart Fail Rev. 2011;16:101-107. doi: 10.1007/s10741-010-9179-1.
3. Lopshire JC, Zipes DP. Device therapy to modulate the autonomic nervous system to treat heart failure. Curr Cardiol Rep. 2012;14:593-600. doi: 10.1007/s11886-012-0292-8.
4. La Rovere MT, Pinna GD, Maestri R, Robbi E, Caporotondi A, Guazzotti G, Sleight P, Febo O. Prognostic implications of baroreflex sensitivity in heart failure patients in the beta-blocking era. J Am Coll Cardiol. 2009;53:193-199. doi: 10.1016/j.jacc.2008.09.034.
5. Floras JS. Sympathetic nervous system activation in human heart failure: clinical implications of an updated model. J Am Coll Cardiol. 2009;54:375-385. doi: 10.1016/j.jacc.2009.03.061.
6. Schwartz PJ, Vanoli E, Stramba-Badiale M, De Ferrari GM, Billman GE, Foreman RD. Autonomic mechanisms and sudden death. New insights from analysis of baroreceptor reflexes in conscious dogs with and without a myocardial infarction. Circulation. 1988;78:969-979.
7. Schwartz PJ, De Ferrari GM, Sanzo A, Landolina M, Rordorf R, Raineri C, Campana C, Revera M, Ajmone-Marsan N, Tavazzi L, Odero A. Long term vagal stimulation in patients with advanced heart failure: first experience in man. Eur J Heart Fail. 2008;10:884-891. doi: 10.1016/j.ejheart.2008.07.016.
8. De Ferrari GM, Crijns HJ, Borggrefe M, Milasinovic G, Smid J, Zabel M, Gavazzi A, Sanzo A, Dennert R, Kuschyk J, Raspopovic S, Klein H, Swedberg K, Schwartz PJ; CardioFit Multicenter Trial Investigators. Chronic vagus nerve stimulation: a new and promising therapeutic approach for chronic heart failure. Eur Heart J. 2011;32:847-855. doi: 10.1093/eurheartj/ehq391.
9. Schwartz PJ, La Rovere MT, Vanoli E. Autonomic nervous system and sudden cardiac death. Experimental basis and clinical observations for post-myocardial infarction risk stratification. Circulation. 1992;85 (1 Suppl):I77-I91.
10. Uthman BM, Reichl AM, Dean JC, Eisenschenk S, Gilmore R, Reid S, Roper SN, Wilder BJ. Effectiveness of vagus nerve stimulation in epilepsy patients: a 12-year observation. Neurology. 2004;63:1124-1126.
11. Shuchman M. Approving the vagus-nerve stimulator for depression. N Engl J Med. 2007;356:1604-1607. doi: 10.1056/NEJMp078035.
12. Vanoli E, De Ferrari GM, Stramba-Badiale M, Hull SS Jr, Foreman RD, Schwartz PJ. Vagal stimulation and prevention of sudden death in conscious dogs with a healed myocardial infarction. Circ Res. 1991;68:1471-1481.
13. De Ferrari GM, Vanoli E, Schwartz PJ. Vagal activity and ventricular fibrillation. In: Levy MN, Schwartz PJ, eds. Vagal Control of The Heart: Experimental Basis and Clinical Implications. Armonk, NY: Futura Publishing Co; 1994:613-636.
14. Li M, Zheng C, Sato T, Kawada T, Sugimachi M, Sunagawa K. Vagal nerve stimulation markedly improves long-term survival after chronic heart failure in rats. Circulation. 2004;109:120-124. doi: 10.1161/01. CIR.0000105721.71640.DA.
15. Sabbah HN, Rastogi S, Mishra S, Gupta RC, Ilsar I, Imai M, Cohen U, Ben-David T, Ben-Ezra O. Long-term therapy with neuroselective electric vagus nerve stimulation improves LV function and attenuates global LV remodelling in dogs with chronic heart failure [abstract]. Eur J Heart Fail. 2005;4(Suppl):166.
16. Zhang Y, Popovic ZB, Bibevski S, Fakhry I, Sica DA, Van Wagoner DR, Mazgalev TN. Chronic vagus nerve stimulation improves autonomic control and attenuates systemic inflammation and heart failure progression in a canine high-rate pacing model. Circ Heart Fail. 2009;2:692-699. doi: 10.1161/CIRCHEARTFAILURE.109.873968.
17. Calvillo L, Vanoli E, Andreoli E, Besana A, Omodeo E, Gnecchi M, Zerbi P, Vago G, Busca G, Schwartz PJ. Vagal stimulation, through its nicotinic action, limits infarct size and the inflammatory response to myocardial ischemia and reperfusion. J Cardiovasc Pharmacol. 2011;58:500-507. doi: 10.1097/FJC.0b013e31822b7204.
18. Tracey KJ. The inflammatory reflex. Nature. 2002;420:853-859. doi: 10.1038/nature01321.
19. Schwartz PJ, Pagani M, Lombardi F, Malliani A, Brown AM. A cardiocardiac sympathovagal reflex in the cat. Circ Res. 1973;32:215-220.
20. Premchand RK, Sharma K, Mittal S, Monteiro R, Dixit S, Libbus I, DiCarlo LA, Ardell JL, Rector TS, Amurthur B, KenKnight BH, Anand IS. Autonomic regulation therapy via left or right cervical vagus nerve stimulation in patients with chronic heart failure: results of the ANTHEM-HF trial. J Card Fail. 2014;20:808-816. doi: 10.1016/j.cardfail.2014.08.009.
21. Zannad F, De Ferrari GM, Tuinenburg AE, Wright D, Brugada J, Butter C, Klein H, Stolen C, Meyer S, Stein KM, Ramuzat A, Schubert B, Daum D, Neuzil P, Botman C, Castel MA, D'Onofrio A, Solomon SD, Wold N, Ruble SB. Chronic vagal stimulation for the treatment of low ejection fraction heart failure: results of the NEural Cardiac TherApy foR Heart Failure (NECTAR-HF) randomized controlled trial. Eur Heart J. 2015;36:425-433. doi: 10.1093/eurheartj/ehu345.
22. Hauptman PJ, Schwartz PJ, Gold MR, Borggrefe M, Van Veldhuisen DJ, Starling RC, Mann DL. Rationale and study design of the increase of vagal tone in heart failure study: INOVATE-HF. Am Heart J. 2012;163:954-962.e1. doi: 10.1016/j.ahj.2012.03.021.
23. De Ferrari GM. Vagal stimulation in heart failure. J Cardiovasc Transl Res. 2014;7:310-320. doi: 10.1007/s12265-014-9540-1.
24. Camm AJ, Savelieva I. Vagal nerve stimulation in heart failure. Eur Heart J. 2015;36:404-406. doi: 10.1093/eurheartj/ehu363.
25. Hamann JJ, Ruble SB, Stolen C, Wang M, Gupta RC, Rastogi S, Sabbah HN. Vagus nerve stimulation improves left ventricular function in a canine model of chronic heart failure. Eur J Heart Fail. 2013;15:1319-1326. doi: 10.1093/eurjhf/hft118.
26. Castoro MA, Yoo PB, Hincapie JG, Hamann JJ, Ruble SB, Wolf PD, Grill WM. Excitation properties of the right cervical vagus nerve in adult dogs. Exp Neurol. 2011;227:62-68. doi: 10.1016/j.expneurol.2010.09.011.
27. Melzack R, Wall PD. Pain mechanisms: a new theory. Science. 1965;150:971-979.
28. Wall PD, Sweet WH. Temporary abolition of pain in man. Science. 1967;155:108-109.
29. Linderoth B, Foreman RD. Physiology of spinal cord stimulation: review and update. Neuromodulation. 1999;2:150-164. doi: 10.1046/j.1525-1403.1999.00150.x.
30. Stiller CO, Cui JG, O'Connor WT, Brodin E, Meyerson BA, Linderoth B. Release of gamma-aminobutyric acid in the dorsal horn and suppression of tactile allodynia by spinal cord stimulation in mononeuropathic rats. Neurosurgery. 1996;39:367-374.
31. Foreman RD, Linderoth B, Ardell JL, Barron KW, Chandler MJ, Hull SS Jr, TerHorst GJ, DeJongste MJ, Armour JA. Modulation of intrinsic cardiac neurons by spinal cord stimulation: implications for its therapeutic use in angina pectoris. Cardiovasc Res. 2000;47:367-375.
32. Southerland EM, Milhorn DM, Foreman RD, Linderoth B, DeJongste MJ, Armour JA, Subramanian V, Singh M, Singh K, Ardell JL. Preemptive, but not reactive, spinal cord stimulation mitigates transient ischemia-induced myocardial infarction via cardiac adrenergic neurons. Am J Physiol Heart Circ Physiol. 2007;292:H311-H317. doi: 10.1152/ajpheart.00087.2006.
33. Olgin JE, Takahashi T, Wilson E, Vereckei A, Steinberg H, Zipes DP. Effects of thoracic spinal cord stimulation on cardiac autonomic regulation of the sinus and atrioventricular nodes. J Cardiovasc Electrophysiol. 2002;13:475-481.
34. Issa ZF, Zhou X, Ujhelyi MR, Rosenberger J, Bhakta D, Groh WJ, Miller JM, Zipes DP. Thoracic spinal cord stimulation reduces the risk of ischemic ventricular arrhythmias in a postinfarction heart failure canine model. Circulation. 2005;111:3217-3220. doi: 10.1161/CIRCULATIONAHA.104.507897.
35. Lopshire JC, Zhou X, Dusa C, Ueyama T, Rosenberger J, Courtney N, Ujhelyi M, Mullen T, Das M, Zipes DP. Spinal cord stimulation improves ventricular function and reduces ventricular arrhythmias in a canine postinfarction heart failure model. Circulation. 2009;120:286-294. doi: 10.1161/CIRCULATIONAHA.108.812412.
36. Liu Y, Yue WS, Liao SY, Zhang Y, Au KW, Shuto C, Hata C, Park E, Chen P, Siu CW, Tse HF. Thoracic spinal cord stimulation improves cardiac contractile function and myocardial oxygen consumption in a porcine model of ischemic heart failure. J Cardiovasc Electrophysiol. 2012;23:534-540. doi: 10.1111/j.1540-8167.2011.02230.x.
37. Tse HF, Turner S, Sanders P, Okuyama Y, Fujiu K, Cheung CW, Russo M, Green MD, Yiu KH, Siu CW. Thoracic spinal cord stimulation for heart failure as a restorative treatment (SCS HEART study): First-in-human experience. Heart Rhythm. 2015;12:588-95. doi: 10.1016/j.hrthm.2014.12.014
38. Feng QP, Carlsson S, Thorén P, Hedner T. Characteristics of renal sympathetic nerve activity in experimental congestive heart failure in the rat. Acta Physiol Scand. 1994;150:259-266. doi: 10.1111/j.1748-1716.1994. tb09685.x.
39. Zucker IM. Neural mechanisms of sympathetic regulation in chronic heart failure. Hypertension. 2006;48:1005-1011.
40. Kopp UC, Cicha MZ, Smith LA. Impaired responsiveness of renal mechanosensory nerves in heart failure: role of endogenous angiotensin. Am J Physiol Regul Integr Comp Physiol. 2003;284:R116-R124. doi: 10.1152/ajpregu.00336.2002.
41. Clayton SC, Haack KK, Zucker IH. Renal denervation modulates angiotensin receptor expression in the renal cortex of rabbits with chronic heart failure. Am J Physiol Renal Physiol. 2011;300:F31-F39. doi: 10.1152/ajprenal.00088.2010.
42. Nozawa T, Igawa A, Fujii N, Kato B, Yoshida N, Asanoi H, Inoue H. Effects of long-term renal sympathetic denervation on heart failure after myocardial infarction in rats. Heart Vessels. 2002;16:51-56.
43. Mulder J, Hökfelt T, Knuepfer MM, Kopp UC. Renal sensory and sympathetic nerves reinnervate the kidney in a similar time-dependent fashion after renal denervation in rats. Am J Physiol Regul Integr Comp Physiol. 2013;304:R675-R682. doi: 10.1152/ajpregu.00599.2012.
44. Hasking GJ, Esler MD, Jennings GL, Burton D, Johns JA, Korner PI. Norepinephrine spillover to plasma in patients with congestive heart failure: evidence of increased overall and cardiorenal sympathetic nervous activity. Circulation. 1986;73:615-621.
45. Petersson M, Friberg P, Eisenhofer G, Lambert G, Rundqvist B. Longterm outcome in relation to renal sympathetic activity in patients with chronic heart failure. Eur Heart J. 2005;26:906-913. doi: 10.1093/eurheartj/ehi184.
46. Davis MI, Filion KB, Zhang D, Eisenberg MJ, Afilalo J, Schiffrin EL, Joyal D. Effectiveness of renal denervation therapy for resistant hypertension: a systematic review and meta-analysis. J Am Coll Cardiol. 2013;62:231-241. doi: 10.1016/j.jacc.2013.04.010.
47. Davies JE, Manisty CH, Petraco R, Barron AJ, Unsworth B, Mayet J, Hamady M, Hughes AD, Sever PS, Sobotka PA, Francis DP. Firstin-man safety evaluation of renal denervation for chronic systolic heart failure: primary outcome from REACH-Pilot study. Int J Cardiol. 2013;162:189-192. doi: 10.1016/j.ijcard.2012.09.019.
48. Verloop WL, Beeftink MM, Nap A, Bots ML, Velthuis BK, Appelman YE, Cramer MJ, Agema WR, Scholtens AM, Doevendans PA, Allaart CP, Voskuil M. Renal denervation in heart failure with normal left ventricular ejection fraction. Rationale and design of the DIASTOLE (DenervatIon of the renAl Sympathetic nerves in hearT failure with nOrmal Lv Ejection fraction) trial. Eur J Heart Fail. 2013;15:1429-1437. doi: 10.1093/eurjhf/hft119.
49. Georgakopoulos D, Little WC, Abraham WT, Weaver FA, Zile MR. Chronic baroreflex activation: a potential therapeutic approach to heart failure with preserved ejection fraction. J Card Fail. 2011;17:167-178. doi: 10.1016/j.cardfail.2010.09.004.
50. Sabbah HN, Gupta RC, Imai M, Irwin ED, Rastogi S, Rossing MA, Kieval RS. Chronic electrical stimulation of the carotid sinus baroreflex improves left ventricular function and promotes reversal of ventricular remodeling in dogs with advanced heart failure. Circ Heart Fail. 2011;4:65-70. doi: 10.1161/CIRCHEARTFAILURE.110.955013.
51. Zucker IH, Hackley JF, Cornish KG, Hiser BA, Anderson NR, Kieval R, Irwin ED, Serdar DJ, Peuler JD, Rossing MA. Chronic baroreceptor activation enhances survival in dogs with pacing-induced heart failure. Hypertension. 2007;50:904-910. doi: 10.1161/HYPERTENSIONAHA.107.095216.
52. de Leeuw PW, Alnima T, Lovett E, Sica D, Bisognano J, Haller H, Kroon AA. Bilateral or unilateral stimulation for baroreflex activation therapy. Hypertension. 2015;65:187-192. doi: 10.1161/HYPERTENSIONAHA.114.04492.
53. Kuck KH, Bordachar P, Borggrefe M, Boriani G, Burri H, Leyva F, Schauerte P, Theuns D, Thibault B, Kirchhof P, Hasenfuss G, Dickstein K, Leclercq C, Linde C, Tavazzi L, Ruschitzka F; Document Reviewers. New devices in heart failure: an European Heart Rhythm Association report: developed by the European Heart Rhythm Association; endorsed by the Heart Failure Association. Europace. 2014;16:109-128. doi: 10.1093/europace/eut311.
54. Abraham WT, Zile MR, Weaver FA, Butter C, Ducharme A, Halbach M, Klug D, Lovett EG, Müller-Ehmsen J, Schafer JE, Senni M, Swarup V, Wachter R, Little WC. Baroreflex activation therapy for the treatment of heart failure with a reduced ejection fraction. JACC Heart Fail. 2015. doi: 10.1016/j.jchf.2015.02.006.
55. Gronda E, Seravalle G, Brambilla G, Costantino G, Casini A, Alsheraei A, Lovett EG, Mancia G, Grassi G. Chronic baroreflex activation effects on sympathetic nerve traffic, baroreflex function, and cardiac haemodynamics in heart failure: a proof-of-concept study. Eur J Heart Fail. 2014;16:977-983. doi: 10.1002/ejhf.138.
56. Schwartz PJ. Cardiac sympathetic denervation to prevent life-threatening arrhythmias. Nat Rev Cardiol. 2014;11:346-353. doi: 10.1038/nrcardio.2014.19.
57. De Ferrari GM, Schwartz PJ. Left cardiac sympathetic denervation in patients with heart failure: a new indication for an old intervention J Cardiovasc Transl Res. 2014;7:338-346. doi: 10.1007/s12265-014-9541-0.
58. Cerati D, Schwartz PJ. Single cardiac vagal fiber activity, acute myocardial ischemia, and risk for sudden death. Circ Res. 1991;69:1389-1401.
59. Malliani A, Recordati G, Schwartz PJ. Nervous activity of afferent cardiac sympathetic fibres with atrial and ventricular endings. J Physiol. 1973;229:457-469.
60. Guo W, Liu F, Fu L, Qu R, Wang G, Zhang C. Effects of high thoracic epidural sympathetic blockade for the treatment of severe chronic heart failure due to dilated cardiomyopathy. Acta Cardiol. 2012;67:533-539.
61. Odero A, Bozzani A, De Ferrari GM, Schwartz PJ. Left cardiac sympathetic denervation for the prevention of life-threatening arrhythmias: the surgical supraclavicular approach to cervicothoracic sympathectomy. Heart Rhythm. 2010;7:1161-1165. doi: 10.1016/j.hrthm.2010.03.046.
62. Collura CA, Johnson JN, Moir C, Ackerman MJ. Left cardiac sympathetic denervation for the treatment of long QT syndrome and catecholaminergic polymorphic ventricular tachycardia using video-assisted thoracic surgery. Heart Rhythm. 2009;6:752-759. doi: 10.1016/j.hrthm.2009.03.024.
63. Conceicąõ-Souza GE, Pêgo-Fernandes PM, Cruz Fd, Guimarães GV, Bacal F, Vieira ML, Grupi CJ, Giorgi MC, Consolim-Colombo FM, Negraõ CE, Rondon MU, Moreira LF, Bocchi EA. Left cardiac sympathetic denervation for treatment of symptomatic systolic heart failure patients: a pilot study. Eur J Heart Fail. 2012;14:1366-1373. doi: 10.1093/eurjhf/hfs132.
64. Schwartz PJ. Autonomic modulation for chronic heart failure: a new kid on the block Eur J Heart Fail. 2012;14:1316-1318. doi: 10.1093/eurjhf/hfs177.